Become a partner

Sweden’s government confirms committment to ATMP

2024-11-12

Ministers for Energy, Business and Industry, Health Care, Social Affairs, Public Health and Education present their updated life science strategy

The 7th of November the Swedish government department updated their strategy for life sciences, towards Sweden being a leading life science nation. The strategy aims to achieve excellence, long-term competitiveness and patient benefit.

Regeringen lanserar uppdaterad life science-strategi

The strategy continues to focus on ATMP and aims to create sustainable growtha and combine economic opportunity with innovative treatments to save lives. The strategy promotes tax incentives for life science, research, entrepreneurship, early and equal patient access to innovative treatments across the country. Collaboration was a strong focus of the event, with Ministers for Energy, Business and Industry, Health Care, Social Affairs, Public Health and Education presenting the strategy as a combined effort.

The ATMP company ILYA Pharma, who have an ex vivo ATMP based on genetically modified bacteria, was mentioned.

The Chair of Föreningen ATMP, Agneta Edberg comments, ”The association ATMP Sweden welcomes the Government’s support for advanced therapies. The eco system in Sweden is based on networks and trust between the different stakeholders, from bench to broad patient access. We look forward to working with the government to create the networks, education and information exchange needed to seamlessly connect healthcare, industry, research, manufacture, authorities and patients, towards novel solutions.”

The Chair of the ‘Samordningsfunktion’, Dag Larsson comments, ”It’s an exciting time in ATMP in Sweden. Swedish healthcare is such an important aspect of patient access to innovative treatments, whether clinical trials or market approved reimbursement. Several points mentioned by the updated strategy touch on the focus areas of the ‘Samordningfunktion’, not only equal patient access to clinical trials and approved treatment, but also the continued support in translating academic research into product development and manufacturing in Sweden.”

If you are interested to learn more about the Swedish ATMP ecosystem, to meet the actors and get involved, join our Annual conference in Malmö on the 25/26th of November! ATMP Sweden 2024 Malmö! | ATMP Sweden

ATMPs are Advanced Therapy Medicinal Products and include medicines based on cells, tissues or gene therapy. ATMPs aim to bring new treatment options to patients *in need, including with genetic disease, cancer, autoimmune disease and degenerative disease.